ActaStim® System
Adjunct to spinal fusion surgery to promote bone healing and reduce non-union
ApprovedActive
Key Facts
Indication
Adjunct to spinal fusion surgery to promote bone healing and reduce non-union
Phase
Approved
Status
Active
Company
About Theragen
Theragen is a private, commercial-stage medical device company that has brought the ActaStim® system to market, representing the first significant advance in spinal fusion bone growth stimulator technology in nearly two decades. Its FDA-approved device utilizes capacitive coupling electrical stimulation to promote bone healing, is designed for continuous wearability, and provides patient compliance data. The company is positioned in the large and growing spinal fusion market, targeting improved patient outcomes and reduced revision surgery rates through its clinically supported technology.
View full company profile